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ABSTRACT
The nuclear lamina (NL) is a structural component of the nuclear envelope and makes extensive
contacts with integral nuclear membrane proteins and chromatin. These interactions are critical for
many cellular processes, such as nuclear positioning, perception of mechanical stimuli from the cell
surface, nuclear stability, 3-dimensional organization of chromatin and regulation of chromatin-
binding proteins, including transcription factors. The NL is present in all nucleated metazoan cells
but its composition and interactome differ between tissues. Most likely, this contributes to the
broad spectrum of disease manifestations in humans with mutations in NL-related genes, ranging
from muscle dystrophies to neurological disorders, lipodystrophies and progeria syndromes. We
review here exciting novel insight into NL function at the cellular level, in particular in chromatin
organization and mechanosensation. We also present recent observations on the relation between
the NL and metabolism and the special relevance of the NL in muscle tissues. Finally, we discuss
new therapeutic approaches to treat NL-related diseases.
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Introduction
The nuclear lamina (NL), a ﬁlamentous protein net-
work underlying the nuclear membranes (Fig. 1), has
emerged as a critical player from basic cell biology to
human health.1 It serves as the anchoring point for
chromatin and transcription factors at the nuclear
periphery and plays a key role in signal transduction
between the cytoskeleton and the nucleus. In addition,
the NL provides mechanical stability to the nucleus,
which is of particular relevance in migrating cells and
cells undergoing physical tension. Reﬂecting its impli-
cation in fundamental cellular processes, the NL is
causatively linked to various severe human diseases
and understanding NL dynamics has become an
important biomedical challenge. For these reasons, the
International University of Andalusia organized
together with Vicente Andres, Tom Misteli and Peter
Askjaer the workshop “The Nuclear Lamina in Health
and Disease” in the historical Spanish town of Baeza
in November 2015. The workshop brought together
scientists working on different aspects of the NL and
highlighted recent advances and remaining challenges.
The exciting presentations and stimulating discussions
inspired us to write an overview of the current situa-
tion of the ﬁeld. Following a brief introduction to the
NL we focus on recent discoveries and we encourage
readers to consult more comprehensive reviews for a
discussion and overview of earlier studies.1,2
The NL is present in all animals and is composed of
type V intermediate ﬁlaments called lamins plus lamin
associated proteins. Mammalian genomes contain 3
lamin genes: LMNA, which encodes lamin A and lamin
C (A-type lamins), as well as LMNB1 and LMNB2 that
encode lamin B1 and B2 (B-type lamins), respectively.
In addition to these 4 major isoforms, the lamin genes
also produce 3 minor isoforms: AD10, C2 and B3.
LMNA is mainly expressed in differentiated cells
whereas all cells express at least one B-type lamin. B-
type lamins are membrane-anchored via farnesylation
of a C-terminal CaaX motif. Pre-lamin A, the lamin A
precursor also contains a CaaX motif and is initially far-
nesylated however lamin C is not. Proteolytic cleavage
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by the ZMPSTE24 protease removes the last 15 amino
acid residues and the hydrophobic farnesyl group to
produce mature lamin A, which is found both at the NL
and in the nuclear interior. Interestingly, speciﬁc LMNA
mutations that cause an internal deletion of amino acids
607-656, including the sequence recognized by
ZMPSTE24, lead to accumulation of aberrant lamin A,
termed progerin, and development of a dramatic pre-
mature aging disease, known as Hutchinson-Gilford
Progeria Syndrome (HGPS).3 Moreover, the recent
identiﬁcation of a single amino acid substitution that
disrupts the ZMPSTE24 cleavage site in prelamin A in a
progeria patient has provided compelling evidence of
the importance of correct lamin A processing.4 In addi-
tion to the connection between the NL and HGPS a
stunning number of disease-causing mutations have
been identiﬁed in LMNA (http://www.umd.be/LMNA/
), as well as in genes encoding NL-interacting proteins
in the inner and outer nuclear membranes. These dis-
eases span a remarkable spectrum of clinical manifes-
tations, including neuropathies, muscle dystrophies,
and lipodystrophies, collectively termed laminopathies
(Table 1). More recently, B-type lamins have also been
linked with human diseases.1,2 The fact that lamins
are broadly expressed but most laminopathies affect
only a single or a few tissue types is surprising and has
triggered several hypotheses. According to the
“mechanical model,” alterations in the NL that affect
its mechanoproperties (nuclear ﬂexibility and stiffness,
transmission of force from the cytoplasm to the
nucleus, etc.) will mainly impact on tissues exposed to
strong mechanical tension, such as muscles. Recent
observations compatible with this model are discussed
in the section “Mechanics of the nuclear lamina and
cell migration” below. The “gene expression model” is
based on the extensive contacts that exist between the
NL and chromatin as well as between the NL and
transcription factors and chromatin modiﬁers. As dis-
cussed in the next section, tissue speciﬁcity in this
model arises from different 3-dimensional (3D)
genome organization and expression of distinct sub-
sets of NL-interacting nuclear envelope proteins.5
Figure 1. Schematic representation of the nuclear envelope. The nuclear envelope consists of an outer (ONM) and an inner nuclear
membrane (INM), which are fused at nuclear pore complexes (NPC). The ONM is continuous with the endoplasmic reticulum (ER) and
associated with ribosomes as well as nesprins and other proteins linking the nucleus to the cytoskeleton. The nuclear lamina is a protein-
aceous network of intermediate ﬁlaments underneath the INM that forms extensive contacts with chromatin and INM proteins. The INM
harbors multiple nuclear envelope transmembrane (NET) proteins, of which only a few are depicted. LEM domain proteins interact with
the chromatin-binding protein BAF and transcription factors, such as SMADs, b-catenin and others, whereas lamin B receptor (LBR) asso-
ciates with heterochromatin protein 1 (HP1) and directly with modiﬁed histones.
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The nuclear lamina as chromatin organizer
Early electron microscopy observations of eukaryotic
nuclei revealed that dark-staining heterochromatin is
enriched at the nuclear periphery (and around nucle-
oli) whereas light-staining euchromatin occupies the
nuclear interior. Fluorescence in situ hybridization
experiments later determined that individual chromo-
somes are conﬁned to “chromosome territories” where
chromosomes with high or low density of active genes
are more frequently positioned toward the nuclear
center or the nuclear envelope, respectively.6 More-
over, for several genes, a correlation has been demon-
strated between locus position within the nucleus and
expression: when these genes are inactive they are pre-
dominantly found at the nuclear periphery but upon
stimuli or cell differentiation they accumulate in the
nuclear interior. It should be noted that there exist
also examples of genes for which such correlation is
absent.6 Experiments to establish cause-consequence
relations through genome manipulations have yielded
conﬂicting results (reviewed in1,6), which in part
might be because of effects of the particular genomic
environment.7 Indeed, recent work by Wendy
Bickmore and colleagues has suggested that changes
in chromatin condensation state, rather than
transcription, regulates gene position.8
To overcome the limitation intrinsic to single-locus
studies, several methods have been developed that
analyze interactions between the NL and chromatin
more systematically. The laboratory of Bas van
Steensel has pioneered the DNA adenine methyltrans-
ferase identiﬁcation (DamID) technique to obtain
global chromatin association proﬁles of NL compo-
nents in a series of cell types. These studies have
revealed that 35-40% of the human genome is orga-
nized into »1300 lamin-associated domains (LADs),
which range from less than 10 kb to more than 10 Mb
(median size of »0.5 Mb).6 LADs have lower gene
density, less transcriptional activity and are enriched
for repressive chromatin marks (H3K27me3 and
H3K9me2). Most LADs are found in several cell types
(“constitutive LADs”) although there are also hun-
dreds of regions of the genome that change association
during differentiation (“facultative LADs”). Interest-
ingly, the genomic positions of constitutive LADs are
conserved between human and mouse.9 It is still not
understood what signatures drive association with the
NL. Globally, constitutive LADs are A/T-rich,9
whereas an analysis of a smaller subset of LADs iden-
tiﬁed elements that target DNA to the NL via the
transcriptional regulators cKrox and YY1, the
histone deacetylase HDAC3 and the inner nuclear
membrane protein lamina-associated polypeptide 2b
(LAP2b).10,11 Similarly, examining the dynamics of
LADs through the cell cycle using an ingenious imag-
ing method led recently to the discovery that LADs
are located in a »1 mm zone underneath the NL,
implying that LADs have a restricted but detectable
mobility in interphase.12 Surprisingly, most LADs do
not return to the nuclear periphery after mitosis, but
localize instead to the nuclear interior and the surface
Table 1. Examples of nuclear lamina-related diseases.
Disease Mutated gene(s)a Affected tissues
Emery–Dreifuss muscular dystrophy LMNA (181350 AD; 616516 AR), EMD (310300 XR);
SYNE1 (612998 AD), SYNE2 612999 AD),
TMEM43 (614302 AD), FLH1 (300696 XR)
Striated muscle
Cardiomyopathy dilated 1A LMNA (115200 AD) Striated muscle
Limb girdle muscular dystrophy type 1B LMNA (159001 AD) Striated muscle
Congenital muscular dystrophy LMNA (613205 AD) Striated muscle
Heart–hand syndrome LMNA (610140 AD) Striated muscle
Torsion dystonia-1 TOR1A (128100 AR) Striated muscle
Greenberg dysplasia LBR (215140 AR) Skeleton
Buschke-Ollendorf syndrome LEMD3 (166700 AD) Skeleton
Familial partial lipodystrophy type 2 LMNA (151660 AD) Adipose
Mandibuloacral dysplasia with lipodystrophy LMNA (248370 AR); ZMPSTE24 (608612 AR) Adipose
Acquired partial lipodystrophy LMNB2 (608709 AD) Adipose
Adult-onset demyelinating leukodystrophy LMNB1 (169500 AD) Central nerve system
Spinocerebellar ataxia-8 SYNE1 (610743 AR) Central nerve system
Charcot–Marie–Tooth disease type 2B1 LMNA (605588 AR) Peripheral nerve system
Pelger-Hu€et anomaly LBR (169400 AD) Blood system
Restrictive dermopathy LMNA (275210 AD); ZMPSTE24 (275210 AR) Skin
Hutchinson–Gilford progeria syndrome LMNA (176670 AD) Multiorgan disease
Nestor-Guillermo progeria syndrome BANF1 (614008) Multiorgan disease
aNumbers in parentheses refer to OMIM entries (http://omim.org), XR X-linked recessive, AD autosomal dominant, AR autosomal recessive.
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of nucleoli. The mechanism controlling this dynamic
behavior of LADs is still unknown, but it is interesting
to note that LADs that re-associate with the NL after
mitosis are enriched for H3K9me2, suggesting a possi-
ble memory function of this modiﬁcation.12 Methyla-
tion of H3K9 was previously identiﬁed to be critical
for anchoring at the nuclear periphery and knock-
down of H3K9 methyltransferases impedes interaction
between LADs and the NL.1,12-14 To further under-
stand the variability in behavior of LADs in individual
cells van Steensel and colleagues recently generated
hundreds of single-cell DamID proﬁles for lamin B1.15
This revealed a spectrum of interaction frequencies
where some LADs were detected in almost all cells
whereas other LADs were detected only occasionally.
The previously deﬁned constitutive LADs showed fre-
quent interactions, suggesting that strong NL associa-
tion is conserved both within and between
populations of cells. Interestingly, behavior of neigh-
boring LADs was found to correlate and have frequent
inter-LAD contacts, indicative of long-range
co-operativity.15
Although A- and B-type lamins differ in their sub-
cellular distribution with the former being more abun-
dant in the nuclear interior, lamin A and lamin B1
DamID proﬁles are highly similar.9,16 This suggests
that interaction with intra-nuclear lamin A might be
involved in the “reshufﬂing” of LADs after mitosis
described above. In support of this hypothesis, knock-
down of lamin A leads to increased interaction of
LADs with lamin B.16 Moreover, chromatin immuno-
precipitation (ChIP) studies in adipose tissue stem
cells identiﬁed lamin A-associated promoters both at
the nuclear periphery and in the nuclear interior.17
Upon differentiation into adipocytes many lamin
A-promoter associations are lost and others are
gained, but only »17% of the changes coincide with
altered transcription.17 In contrast to the similar
DamID proﬁles, Roland Foisner and colleagues
recently reported that ChIP of lamin A and lamin B1
identiﬁes different chromatin domains when genomic
DNA is fragmented by relatively mild sonication.18
Under these conditions, lamin B1 interacts with gene
poor and non-transcribed regions that overlap with
DamID LADs. In contrast, lamin A peaks are enriched
for transcribed genes and active chromatin marks,
such as histone H3K4me3 and H3K9ac, and coincide
with the ChIP proﬁle of LAP2a. LAP2a, which in dis-
tinction to LAP2b is not membrane-associated,
presumably plays an important role in these contacts,
because lamin A interactions with euchromatin are
reduced in LAP2a¡/¡ cells.18 Interestingly, stronger
sonication to produce shorter chromatin fragments
shifts the population of lamin A-interacting domains
toward inactive chromatin, eventually generating a
high overlap with lamin B1 ChIP and DamID
proﬁles.18,19 This demonstrates that lamins probably
interact with several classes of chromatin and illus-
trates the potential bias that experimental procedures
might impose on the results. The interaction between
lamin A and LAP2a is also relevant in cells from
HGPS patients, in which expression of LAP2a nega-
tively correlates with progerin levels.20 HGPS cells
proliferate slower, but ectopic expression of LAP2a
counteracts this phenotype, partly by stimulating the
production of extracellular matrix components.20
A crucial question in understanding NL-chromatin
interactions is which factors are responsible for
recruiting and anchoring chromatin at the nuclear
periphery? Several proteins and chromatin modiﬁca-
tions have been implicated (see1 for original referen-
ces), but recent studies have identiﬁed novel players
and new mechanisms. Surprisingly, lamins are dis-
pensable for organization of the genome in LADs and
inter-LAD regions, at least in murine embryonic stem
cells, which indicates that other nuclear envelope pro-
teins can independently tether chromatin to the
nuclear periphery.21 One interesting candidate is the
inner nuclear membrane lamin B receptor (LBR) pro-
tein, which recognizes heterochromatic histone
H4K20me2 via its Tudor domain.22 In an elegant
study of 39 different mammals, Irina Solovei and col-
leagues compared the distribution of heterochromatin
in retinal cells versus endothelial cells: in nocturnal
species the distribution is inverted in retinal cells with
heterochromatin accumulating in the nuclear center
and this correlates with absence of both lamin A/C
and LBR in these cells.23 In contrast, heterochromatin
is at the nuclear periphery of retinal cells in diurnal
animals which all express either lamin A/C or LBR.
Further analysis of lamin A/C and LBR in mice
revealed that many cell types express only one of
them, often with LBR preceding lamin A/C. Interest-
ingly, inversion of heterochromatin distribution was
observed in Lbr¡/¡ mice in tissues that do not express
lamin A/C, and widespread inversion was also
observed in mice lacking both lamin A/C and LBR.23
Although lamin A/C and LBR are partially redundant
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in perinuclear tethering of heterochromatin, they have
opposite effects on transcription in myoblasts: mus-
cle-related genes have reduced and increased expres-
sion in Lmna¡/¡ and Lbr¡/¡ myoblasts, respectively.23
Whereas LBR may interact directly with heterochro-
matin via its Tudor domain, Lamin A/C requires co-
factors, such as the inner nuclear membrane protein
emerin, to efﬁciently anchor chromatin to the NL.23
Expression of emerin varies between tissues and is rel-
atively abundant in contractile tissues both in mice
and Caenorhabditis elegans,23,24 suggesting that
emerin might be particularly relevant for nuclear orga-
nization in those tissues. Indeed, although global
DamID proﬁles of lamins and emerin are very simi-
lar,21 experiments in C. elegans identiﬁed local differ-
ences, including speciﬁc enrichment of emerin at
many muscle and neuronal genes.25 Interestingly, loss
of emerin leads to increased lamin association to these
chromatin regions, and this was associated with
altered neuromuscular junction activity indicating
that the 2 proteins compete for binding.25 Eric
Schirmer and colleagues have systematically screened
a series of less characterized inner nuclear membrane
proteins and found that several of these (NET5,
NET29, NET39, NET45 and NET47) are able to
induce relocation of particular loci and entire chromo-
somes to the nuclear periphery.26 Because these pro-
teins are expressed in tissue-speciﬁc manners, they are
attractive candidates for further analysis of cell type-
speciﬁc nuclear organization. The Polycomb group
(PcG) protein Ezh2 was recently also found to act
together with lamin A/C to regulate muscle-related
genes.27 Chiara Lanzuolo and colleagues demonstrated
that lamin A/C interacts with PcG proteins and affects
their intranuclear dynamics. In addition, loss of lamin
A/C expression impairs the repressive action of PcG
and accelerates differentiation of myoblasts to myo-
tubes.27 Another remarkable example of the dynamics
of interactions between the NL and chromatin was
reported in a study of circadian genes.28 Anita G€ond€or
and colleagues identiﬁed an inter-chromosomal net-
work of circadian genes whose relative position within
the nucleus oscillates with a periodicity of »24 h. The
recruitment to the nuclear periphery coincides with
the appearance of H3K9me2 and reduced expression.
Interestingly, knockdown of the chromatin regulator
CTCF and its cofactor PARP1 or inhibition of the
H3K9 methyltransferase G9a suppresses oscillation of
gene positioning and transcription.28
Gene position relative to the NL (or other subnu-
clear structures) can be precisely determined by ﬂuo-
rescence in situ hybridization (FISH), but the
laborious nature of the protocol has prevented appli-
cation of this method beyond studies on relatively few
loci and/or gene positioning factors. To overcome this
limitation, Tom Misteli and co-workers developed a
high-throughput automated FISH workﬂow and dem-
onstrated its usefulness by screening an siRNA library
targeting 669 selected nuclear proteins.29 The effects
on positioning of 4 endogenous loci were analyzed in
cells in 384-well plates and led to the identiﬁcation of
50 validated hits. Twenty-six factors affected the posi-
tion of a single locus, whereas 18 factors affected 2
loci. The factors that affected multiple loci did so in a
variable manner: 11 of them caused peripheral and
central loci to move toward and away from the nuclear
center, respectively, whereas the remaining 13 factors
induced a unidirectional shift in intranuclear posi-
tion.29 Together, this demonstrates that gene position-
ing within the nucleus is a combinatorial process that
involves multiple factors acting at speciﬁc loci. As
observed in other studies, repositioning of genes does
not necessarily alter their expression level, but, inter-
estingly, requires progression through S phase.29
The NL also plays important roles during viral
infection. The lamin-binding protein Barrier to auto-
integration factor (BAF) was identiﬁed almost 2 deca-
des ago based on its role in integration of retroviral
DNA into the host cell genome (see references in30).
More recently, Marina Lusic and colleagues discov-
ered that human immunodeﬁciency virus 1 (HIV-1)
preferentially integrates into perinuclear chromatin in
the vicinity of nuclear pores and outside LADs.31
ChIP analysis of several nucleoporins demonstrated
an interaction with integration hot spots and viral
DNA, whereas knockdown of the same nucleoporins
impairs proviral transcription. Whether the frequent
integration into nuclear pore-associated open chroma-
tin reﬂects an active role of nucleoporins and/or rather
a passive exclusion from closed LAD chromatin is an
interesting question for future studies.31
Mechanics of the nuclear lamina and cell
migration
Cells in multicellular organisms are constantly
exposed to various forms of mechanical stress and
their response is fundamental for proper cellular
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functioning. These responses depend on the NL as
well as linker of nucleoskeleton and cytoskeleton com-
plex (LINC) proteins, such as SUN and KASH domain
proteins, connecting the nuclear envelope to cyto-
plasmic ﬁlamentous actin, intermediate ﬁlaments and
microtubules (Fig. 2).
Tissues exhibit a spectrum of microelasticity
diverging from soft tissues like brain or adipose tissue,
which are exposed to low physical stress, to stiffer tis-
sues like bone or muscle that have to deal with high
stress. Recent proteomics analyses of tissue samples
and cells by Dennis Discher and colleagues have
shown that proper behavior of stiff tissues depends on
the ratio between lamin A, which is »30-fold more
abundant in stiff vs. soft tissues, and lamin B.32 On the
other hand, the expression of B-type lamins varies
minimally between tissues and consequently they
dominate in softer tissues like brain.32 Moreover, col-
lagens in the extracellular matrix (ECM) are a key
determinant of tissue stiffness and scale with tissue
stiffness whereas lamin A levels respond to changes in
tissue elasticity.32 Cellular stress is transmitted to the
Figure 2. Nuclear envelope protein networks controlling nuclear positioning and sensing tension. Trimeric SUN-domain proteins in the
INM associate with KASH-domains of nesprins embedded in the ONM and the nuclear lamina to form linker of nucleoskeleton and cyto-
skeleton (LINC) complexes. In the cytoplasm, nesprins bind a variety of cytoskeletal structures, including ﬁlamentous actin, intermediate
ﬁlaments and microtubules. In addition, LEM-domain proteins are also involved in anchoring of centrosomes to the nuclear envelope
via unknown cytoplasmic or ONM proteins [24, 86]. Together, these contacts serve as sensors and transducers of mechanical stimuli
from the cytoskeleton to regulate gene transcription as well as to position the nucleus within the cell. The ratio of A- and B-type lamins
in the nuclear lamina and phosphorylation of lamins controls nuclear envelope ﬂexibility, which is important during cell migration and
tissue deformation.
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nucleus and cytoskeletal tension increases with the
stiffness of the matrix.33 Cells growing on a soft matrix
(i.e. low stress) are more rounded with a highly wrin-
kled nuclear envelope, while on stiff matrix (i.e., high
stress) the nucleus is ﬂattened with a smoother NL,
thus matrix stiffness alters the NL structure.32 How-
ever, changes in the NL also affect the cytoskeleton.
Lamin A interacts with actin and actin-binding pro-
teins through components of the LINC (Fig. 2) and
lamin A knockdown in mesenchymal stem cells leads
to repression of actomyosin cytoskeleton-related
genes, particularly components of the serum response
factor pathway.34 It has been demonstrated that lamin
A/C is phosphorylated both during interphase and,
more prominently, during mitosis where phosphory-
lation promotes disassembly of the NL.1,35 Interest-
ingly, lamin A phosphorylation is stress-dependent,
with low stress favoring lamin A phosphorylation and
possibly lamin A solubilization.32,34 Moreover,
decreased expression of lamin A causes reduction of
myosin-IIA protein and mRNA levels, whereas
expression of an non-phosphorylatable lamin A in
lamin A depleted cells caused an increase of myosin-
IIA quantity.34 In addition, the NL has been shown to
act in tumor metastasis, more speciﬁcally to increase
the resistance of tumor cells to ﬂuid shear stress (FSS)
in the bloodstream.36 During metastasis, cancer cells
detach from the primary tumor and enter the blood-
stream where they have to cope with hemodynamic
shear forces while circulating to other organs. Meta-
static breast cancer cells are more resistant than non-
malignant epithelial cells to elevated FSS in vitro and
lamin A depletion reduces their resistance to FSS-
induced cell death by increasing tumor cell apoptosis
further highlighting the protective role of lamin A
when cells are exposed to stress.36
Cell migration is a fundamental part of many bio-
logical processes, including tissue formation, wound
healing, cancer invasion and metastasis. During
migration, the nucleus, which is the largest and the
stiffest organelle of the cell, typically has to undergo
dramatic deformations (Fig. 2). Cell migration
requires actin polymerization, integrin-mediated
adhesion to the ECM as well as ECM cleavage by cell
surface metalloproteinases (MMPs) and ﬁnally con-
traction of the cell body followed by cell translocation
mediated by the actomyosin cytoskeleton.37 Cell
migration was previously observed on ﬂat, 2D sub-
strates, but most physiological processes take place in
3D environments. This has given rise to emerging
research of migration processes based on 3D devi-
ces.37,38 These studies have demonstrated that cell
migration is a linear function of pore size with the col-
lagenase MT1-MMP being a limiting factor in 3D col-
lagen matrices and that both integrin-based traction
force and actomyosin contractility are necessary for
cell migration in conﬁned space. In the absence of
MMPs, cell passage in a conﬁned space induces fur-
ther deformation of the nucleus, reaching a maximal
compression when the nuclear diameter is reduced to
10% of its original size.37,38 Cells present variability of
nuclear shape, hence migrating cells present different
forms of nuclear deformation; mononuclear cells dis-
play elongated hourglass-like or cigar-shaped defor-
mations whereas polymorphonuclear cells produce a
pearl chain-like conﬁguration.
It has been shown that 3D migration through nar-
row pores is sensitive to lamin A levels, since overex-
pression or partial knockdown of lamin A limits or
promotes cell passage, respectively.38,39 However, in
accordance with the protective role of the NL against
stress, partial lamin A knockdown also causes an
increase in apoptosis after cell migration through nar-
row pores, whereas further suppression of lamin A
knockdown impairs resistance to migration stress and
causes pronounced apoptosis.39 Furthermore, the stoi-
chiometry between A and B-type lamins inﬂuences
the physical plasticity during cell migration with high
lamin A:B ratios leading to persistent nuclear shape
changes after cell migration.39 Depletion of lamins
also correlates with the frequency of local nuclear rup-
ture when tumor cells migrate in conﬁning 3D-envi-
ronments.40 Local nuclear envelope rupture is
characterized mixing of nuclear and cytoplasmic fac-
tors, protrusions of chromatin through the nuclear
envelope and increased DNA damage, whereas the
endosomal sorting complexes required for transport-
III (ESCRT-III) machinery is crucial for restoring the
integrity of the nuclear envelope.40-42
Cells migrating across 2D surfaces use lamellipodial
protrusions at their leading edge, however Kenneth
Yamada and coworkers have shown that cells moving
through a physiological 3D matrix can generate cylin-
drical, blunt protrusions called lobopodia and migrate
in a lamellipodia-independent manner.43 Further-
more, they propose that during cell migration through
3D environments, the nucleus functions as a piston to
generate differences in hydrostatic pressure in front of
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and behind the nucleus. This involves the outer
nuclear membrane protein nesprin-3 as a linker
between the nucleus and cytoskeleton, which pulls the
nucleus forward by actomyosin contraction.
The nuclear lamina and metabolism
Several recent studies investigate the link between
laminopathies and metabolic pathways, including
post-translational sugar modiﬁcation of serine or thre-
onine residues by monosaccharide b-N-acetylglucos-
amine (O-GlcNAc).44 O-GlcNAc is added and
removed by O-GlcNac transferase (OGT) and O-
GlcNacase (OGA) enzymes, respectively, and can act
as a rival mechanism to protein phosphorylation.45 O-
GlcNAc modiﬁcation is implicated in the regulation
of transcription and translation, regulates protein traf-
ﬁcking and turnover, modulates insulin signaling and
ﬁnally is implicated as an early response to cellular
stress.45,46 Moreover, overexpression of OGT and
OGA affects mitosis and cytokinesis and has been
implicated in diabetes, aging, cancer and heart
diseases.45
Proteins of the nuclear pore complexes are heavily
modiﬁed by O-GlcNAc,46 but it was recently found
that emerin, apart from being a highly phosphorylated
protein both during mitosis and interphase is also O-
GlcNAcylated on at least 8 residues.44 Mutation of
Ser53 or Ser54 located close to the LEM-domain in
emerin severely disrupts O-GlcNAcylation both in
vitro and in vivo. Interestingly, substitution of Ser54
for phenylalanine (S54F) does not affect emerin
expression but is sufﬁcient to cause Emery-Dreifuss
muscular dystrophy. In cell extracts, the interaction of
emerin with BAF is enriched in histone and lamin B-
containing fractions, and O-GlcNAcylation of emerin
on Ser173, which is outside of the LEM domain, pro-
motes association of emerin with BAF.44 Post-transla-
tional sugar modiﬁcation by OGT and OGA enzymes
also inﬂuences chromatin organization, since all core
histones are GlcNAcylated.46 Moreover, recent studies
have proposed that histone H2B GlcNAcylation on
Ser112 functions as an epigenetic mark involved in
remodeling of LADs after adipogenic induction.47
While A- and B-type lamins form immobile protein
networks, BAF is highly mobile both in human cell
lines and in C. elegans embryos. Interestingly, C. ele-
gans BAF mobility is regulated by environmental
stress, since GFP-BAF-1 is immobilized by dietary
restriction or heat shock, linking cell metabolism to
NL dynamics.30 Whether the changes in mobility are
due to modiﬁcations of BAF or its interaction part-
ners, such as emerin, is currently unknown, but it
would be relevant to investigate O-GlcNAcylation
levels.
Speciﬁc LMNA mutations affect adipose tissues
causing lipodystrophies, characterized by severe meta-
bolic alterations, fat atrophy and pathological accumu-
lation of prelamin A at the nuclear periphery of
affected cells (Table 1). Interestingly, HGPS patients
also develop lipodystrophy and prelamin A accumula-
tion affects human mesenchymal stem cell-derived
adipocytes, leading to smaller lipid droplets, increased
lipolysis, alteration in the structure of the endoplasmic
reticulum, partial depolarization of mitochondria
membranes and alteration of the lipid proﬁle.48,49
In conclusion, these observations illustrate the high
complexity of protein interactions at the NL and point
to extensive cross-talk between the NL and cell
metabolism.
The nuclear lamina and muscles
All three major muscle groups, skeletal, cardiac and
smooth muscle, are affected in various laminopathies.
In progeria, vascular smooth muscle cell (VSMC) dys-
function and loss is the cause of premature death due
to accelerated atherosclerosis, leading to heart attack
and stroke. It appears that VSMCs are highly suscepti-
ble to the accumulation of mutant forms of prelamin
A (progerin) in HGPS. This notion is further sup-
ported by ﬁndings in the general population showing
that prelamin A species speciﬁcally accumulate in
aged and diseased VSMCs and can act as a biomarker
for vascular aging and disease.3,50-52
Mouse models either expressing progerin or lacking
ZMPSTE24 and thus accumulating prelamin A
develop cardiovascular defects. These include VSMC
loss and extracellular matrix changes which culminate
in calciﬁcation of the vessel wall. Vascular calciﬁcation
is a key feature of vascular aging and is also prevalent
in patients with HGPS. Recent studies by the Andres
group have shown that calciﬁcation is exacerbated in
‘knock-in’ mice carrying the Lmna G609G mutation
that leads to progerin production. These mice develop
calciﬁcation due to defective extracellular metabolism
of the key calciﬁcation inhibitor pyrophosphate (PPi)
in VSMCs.53 This deﬁciency in progerin-expressing
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VSMCs was associated with increased tissue expres-
sion and activity of tissue-nonspeciﬁc alkaline phos-
phatase (TNAP), which hydrolyzes PPi to inorganic
phosphate, and mitochondrial dysfunction leading to
reduced synthesis of the PPi substrate ATP through
mechanisms that remain unclear. The absence of ath-
erosclerosis in these mouse models is not unexpected,
as mice do not naturally develop the disease. There-
fore we await further studies investigating how prela-
min A can impact on atherosclerotic disease in
appropriate models. Interestingly these studies may
not be conﬁned to studies of VSMCs. Recent data sug-
gests that the NL is important for T-cell function.54
These cells are also a component of the chronic
inﬂammation in atherosclerotic plaques suggesting
that dysfunction in additional cell types may contrib-
ute to the accelerated atherosclerosis in HGPS.
Studies of normal human VSMCs in vitro have
begun to dissect further how prelamin A can impact
on cardiovascular pathologies. Using an in vitromodel
of VSMC calciﬁcation it was found that expression of
prelamin A accelerated calciﬁcation. The mechanism
involves increased DNA damage accumulation and
the onset of premature senescence, leading to the
induction of the senescence associated secretory phe-
notype (SASP). Many of the growth factors and
inﬂammatory cytokines associated with the SASP,
including BMP2 and IL6, have been shown to acceler-
ate VSMC calciﬁcation.51 Importantly, the greatest
risk factor for cardiovascular disease is age, and prela-
min A has been shown to interfere with DNA damage
repair in a number of ways leading to premature
senescence of cells.55 In VSMCs, this interference may
also impact on speciﬁc pathways. For instance, lamin
A and its binding partner nesprin-2 have been discov-
ered to play a role in regulating VSMC proliferation
and DNA repair by stabilizing intranuclear active
ERK complexes at PML bodies.52 Clearly, further
work is required to fully deﬁne the mechanisms
whereby prelamin A drives premature vascular aging.
Mutations in LMNA and/or EMD (encoding
emerin) cause Emery Dreifuss Muscular Dystrophy,
which affects both skeletal and cardiac muscle leading
to conduction defects. Other LMNA mutations affect
only the heart, manifesting as dilated cardiomyopathy
(DCM) or mainly skeletal muscle as occurs in various
limb girdle muscular dystrophies (see Table 1). There
are no clear genotype-phenotype correlations for these
diseases making it difﬁcult to pinpoint an overarching
mechanism for each disease state. However, observa-
tions by Giselle Bonne, who has performed seminal
work in unraveling the role of the NL in muscle syn-
dromes, suggest that cardiac defects might be the
major cause of death in these diverse laminopathy
syndromes.56
One of the limitations has been that animal models
do not reiterate all aspects of human disease. While
most human LMNAmutations exert a dominant effect
and show a phenotype in heterozygotes, homozygosity
of mutations is often required in animal models.
Indeed, deletion of genes such as EMD, which causes
classic EDMD in man apparently show no phenotype
even when homozygous in mice. However, the Bonne
laboratory has recently developed a model where for
the ﬁrst time a heterozygous animal develops a cardiac
speciﬁc phenotype. This model is a ‘knock-in’ of the
LMNADK32 human mutation.57 Mice develop DCM
and die between 35 and 70 weeks of age. Interestingly,
the disease appeared to have 2 phases. The ﬁrst was
haploinsufﬁciency of lamin A, which is a known cause
of DCM, most likely associated with defects in
mechanical function/signaling. This was followed by a
later phase where lamin A levels were increased and
this was associated with defects in the ubiquitin-pro-
teosomal system; a key indicator of later stage heart
failure. The pathogenesis of disease in this model
highlights the complexities of deﬁning molecular
mechanisms in muscle laminopathies. The heart con-
tinuously undergoes adaptive remodeling in response
to changes in mechanical signaling inducing a contin-
uum of changes making cause and effect difﬁcult to
dissect apart. One way forward will be to compare var-
ious models of NL disruption. If disruption of mecha-
nosignaling is the main driver of early disease, then
models where other LINC components, such as SUN
or nesprin proteins, are disrupted might be informa-
tive (Fig. 2). So far it has been shown that deletion of
the C-terminal region of both nesprin-1 and ¡2 is
required to induce cardiac symptoms in mice58 and
we now await further studies of LINC complex and
NL binding partner knockouts, particularly those that
are muscle speciﬁc, to further deﬁne disease processes.
Muscle, due to its structure and accessibility pro-
vides ideal material for gene therapy based techniques
to treat laminopathies. Skeletal muscle is particularly
amenable to localized delivery of nucleic acids and a
recent technology known as exon-skipping which can
be used to delete mutant exons while leaving the
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nucleic acid coding sequence in frame has been suc-
cessfully applied to other skeletal muscle dystrophies
such as Duchenne Muscular Dystrophy. Studies are
emerging that have begun to explore the use of this
technology in laminopathies and this and other inno-
vative technologies aimed at normalizing LMNA
mutations are likely to be implemented in the coming
years.59
Development of therapeutic strategies for lamin-
related diseases
In the last decade, the identiﬁcation of molecular
mechanisms contributing to cellular decline in lamin-
related diseases and the generation of mouse models
has expedited the search for therapies to ameliorate
the pathophysiology of these diseases. Much emphasis
has been placed on the treatment of HGPS. HGPS
patient-derived cells and mouse models of progeria
have been valuable tools to design therapies for treat-
ment. Initial preclinical studies identiﬁed farnesyl-
transferase inhibitors (FTIs) and prenylation
inhibitors (statins and aminobisphosphonates) as
potential beneﬁcial treatments for HGPS. The encour-
aging results in mice led to the ﬁrst clinical drug trial
for children with progeria utilizing the FTI lonafarnib.
However, the improvements were minor and FTIs
alone are far from curing the disease.3,60 A second trial
with the triple combination lonafarnib, a bisphospho-
nate (zoledronate) and a statin (pravastatin) is
ongoing.
In addition to prenylation inhibitors, therapeutic
strategies are targeting other post-translational modi-
ﬁcations of progerin. In particular, reduced expression
of ICMT, the enzyme responsible for carboxymethyla-
tion of the farnesylcysteine of lamin A/progerin, has a
dramatic effect ameliorating the phenotype of progeria
mice, signiﬁcantly increasing lifespan.61 This study
also demonstrated that activation of the AKT/mTOR
pathway is responsible for the improvement of the
phenotype of progeria cells. Consistent with this
notion, depletion or inhibition of ICMT increases
AKT-mTOR signaling and delays senescence in
HGPS cells, while the mTOR inhibitor rapamycin
reduces the proliferation of HGPS cells. These data
suggest that ICMT and the AKT/mTOR pathway
could be considered as targets for the treatment of
HGPS patients. However, other reports have shown a
beneﬁcial effect of rapamycin on the phenotype of
HGPS patient cells, primarily by increasing progerin
clearance by autophagy.62,63 Rapamycin is an FDA-
approved drug used as an immunosuppressant, and
thus the use of this drug in HGPS patients has been
gaining momentum. Along the same line, sulforaph-
ane, an antioxidant that stimulates proteasome activity
and autophagy, enhances progerin clearance in HGPS
cells. Sulforaphane has been suggested as a promising
therapeutic avenue for children with HGPS.64 More-
over, resveratrol, an enhancer of SIRT1 deacetylase
activity, alleviates progeroid features and extends life-
span in progeria mice, although the effect on survival
is relatively modest.65
New evidence has also linked lamin dysfunction
with reduced levels of antioxidant enzymes and
increased generation of reactive oxygen species (ROS)
and mitochondrial dysfunction.53,66-68 Persistent accu-
mulation of ROS can oxidize cysteines in lamins, caus-
ing NL structural alterations,66 which could contribute
to the increased levels of DNA damage and the geno-
mic instability that characterize lamin-deﬁcient cells.
Support for this notion is the fact that treatment of
progeroid cells with the ROS scavenger N-acetyl cyste-
ine reduces the amount of unrepairable DNA dam-
age.69 Therefore, compounds that reduce the ROS
levels could represent yet another strategy to reduce
genomic instability in lamin-related diseases.70
All these studies have generated controversy about
the best treatment regimen for HGPS patients, espe-
cially because prenylation inhibitors can induce a vari-
ety of noxious side effects. Moreover, studies on
mesodermal stem cells derived from HGPS pluripo-
tent stem cells (iPS) with all 3 treatments (FTI, ZoPra,
and/or rapamycin) showed tremendous variability in
the phenotypes improved by the different treatments,
as well as evidence for cytostatic effects with different
combinations.71 The current view is that we need to
be cautious when designing clinical trials for HGPS
patients, because the toxicity associated with some of
these treatments on the long run might undermine
the beneﬁts. Thus, the main challenge in the ﬁeld of
progeria in the years to come is to ﬁnd strategies to
improve such dramatic phenotypes while lowering
toxicity.
In the workshop “The Nuclear Lamina in Health
and Disease,” researchers discussed new compounds
showing beneﬁcial effects in progeria models. The
small molecule “remodelin,” an inhibitor of N-acetyl-
transferase-10 (NAT10) has been recently shown to
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improve a variety of phenotypes in both lamin A/C-
depleted cells and HGPS patient-derived cells. Remod-
elin treatment restores nuclear shape, improves chro-
matin organization, and decreases DNA damage in
these cells.72 The effect of remodelin rescuing nuclear
shape defects seems to be connected to NAT10 orga-
nizing the microtubule network. In addition, remode-
lin treatment improves DNA replication, enhances
proliferation and decreases senescence. Current stud-
ies are investigating the effect of remodelin on gene
expression and testing a potential beneﬁt of remodelin
treatment in mouse models of laminopathies. Small
molecules such as remodelin might provide alternative
strategies for treating laminopathies and premature
aging diseases. In addition, retinoids are emerging as
potential compounds with a beneﬁt in progeria mod-
els. In vitro studies have shown that these compounds
regulate directly expression from the LMNA gene,
leading to decreased expression of progerin in HGPS
patient-derived ﬁbroblasts. Retinoic acid responsive
elements (L-RARE) are present in the LMNA gene
promoter,32 which upon treatment with all trans reti-
noic acid (ATRA) downregulate progerin expression.
Importantly, ATRA synergizes with rapamycin in
reducing progerin levels, restoring heterochromatin
organization and nuclear shape, reducing DNA dam-
age markers, and improving cell viability.73 Preclinical
studies with retinoic acids alone or in combination
with rapamycin are needed to determine a potential
beneﬁt in vivo. Other studies have revealed an unprec-
edented role for the active vitamin D metabolite 1,25
a-dihydroxyvitamin D3 (1,25D) rescuing DNA repair
defects in lamin A/C-deﬁcient cells.74-76 Unpublished
data from Susana Gonzalo and colleagues also indi-
cates that vitamin D/vitamin D receptor (VDR) sig-
naling ameliorates the phenotypes of HGPS patient-
derived cells. Future studies need to determine if
1,25D, ATRA, or the combination, can reduce pro-
gerin levels in vivo without causing toxicity, resulting
in a general amelioration of the premature aging
phenotype.
In addition to the above approaches to target
known HGPS-affected pathways with therapeutic
purposes, unbiased global-scale screenings are being
implemented to identify new molecular mecha-
nisms behind disease pathology, new effectors, and
new compounds to prevent progerin-induced
effects. Tom Misteli and colleagues recently per-
formed a high-throughput, high-content imaging
based screening method to identify small molecules
that ameliorate progeria-induced cytotoxicity. The
screening of a library of FDA approved drugs iden-
tiﬁed retinoids as a class of compounds reversing
the phenotypes of HGPS patient cells.77 These
results reinforce the need to test in vivo the efﬁcacy
of retinoids ameliorating the pathophysiology of
HGPS. It is possible that the best strategy is the
utilization of combination therapy to obtain syn-
ergy among compounds, while reducing the doses
of each single compound in order to reduce toxic-
ity. Other approaches utilized by the Misteli team
include mapping on a global scale the interactome
of lamin A, and how disease-associated mutations
modify the map. The yeast 2-hybrid (Y2H) screen-
ing of an ORFeome library comprising over 12,000
genes for lamin A/C-binding proteins identiﬁed
new proteins whose interaction is disrupted by dis-
ease-linked lamin A mutations.78 The screen identi-
ﬁed 225 progerin-speciﬁc interactions, 51 proteins
that interacted with both lamin A and progerin,
and 61 interactions speciﬁc from lamin A. The
concomitant analysis of localization pattern
revealed that although the majority of progerin-
speciﬁc proteins (89%) are at the nuclear periphery,
only half of lamin A-binding proteins accumulate
at the nuclear envelope. Gene Ontology (GO) anal-
ysis indicates that progerin-speciﬁc and lamin A-
speciﬁc interactors are functionally distinct. Lamin
A interactors were enriched for nuclear envelope
and lamina components, while progerin interactors
comprised mostly integral and intrinsic membrane
proteins with channel and transport function.
These included components of the ER and proteins
that participate in vesicle-mediated transport, mem-
brane organization, and overall protein localization.
Altogether, these data suggest that the tissue speci-
ﬁcity of laminopathies might be driven by gain or
loss of tissue-speciﬁc lamin A/C interactions. These
interactions can sequester proteins either at the
nuclear periphery or in the nuclear interior, alter-
ing their function.
The sequestration of proteins in the nucleus seems
to be a recurrent theme for progeria. The association
of chromatin remodeling factors such as NURD, and
transcription factors such as Fos, Sp1, or SKIP with
the NL regulate their function.1,49 For example, the
sequestration of transcription factors by progerin is
responsible for the loss of NURD complex function
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observed in HGPS and in physiological aging. The
association of NURD complex with the NL stabilizes
the complex, which in the absence of lamins is tar-
geted to degradation.79
Another subject of active research in the ﬁeld of
progeria is the role of telomerase counteracting pro-
gerin toxicity. Accelerated telomere shortening is a
hallmark of HGPS patient cells, which contributes to
accumulation of DNA damage, genomic instability
and proliferation defects. As such, expression of telo-
merase in HGPS cells prevents both proliferation
defects and DNA damage, and suppresses changes in
gene expression induced by progerin.80,81 Unpub-
lished studies performed by Colin Stewart and col-
leagues in embryonic stem cells (ESCs), which express
B-type lamins but not lamin A, showed high expres-
sion of telomerase. Upon differentiation, lamin A
expression is induced, concomitant with a reduction
in telomerase levels. Expression of lamin A or pro-
gerin in ESCs did not show an overt effect, with cells
still retaining their stemness and pluripotent charac-
teristics, as well as a normal growth rate. However, the
viability and proliferation of differentiated stem cell
derivatives expressing progerin is signiﬁcantly com-
promised, and differentiated cells accumulate DNA
damage. Thus, one of the questions raised by these
ﬁndings is whether the decrease in telomerase during
differentiation of ESCs is responsible for the DNA
damage. In fact, the Stewart’s team discovered that tel-
omerase-deﬁcient ESCs are severely compromised in
their tolerance to progerin, supporting the notion that
telomerase protects from the detrimental effects of
progerin.
Moreover, analysis of protein-protein interac-
tions by the Stewart’s team revealed that LAP2a
interacts more weakly with progerin than with
lamin A82. Super-resolution microscopy showed
that LAP2a association with telomeres is impaired
in HGPS cells. Their studies suggest that the
impaired interaction of progerin with LAP2a con-
tributes to HGPS phenotypes. As such, LAP2a
depletion in HGPS cells enhances their prolifera-
tion defects, while increasing LAP2a levels restores
normal growth. The loss of LAP2a in progerin-
expressing cells also contributes to the characteris-
tic loss of heterochromatic marks such as
H3K27me3, a hallmark of HGPS cells. These ﬁnd-
ings provide novel insights into the pathophysiol-
ogy underlying HGPS, and how the NL regulates
proliferation and chromatin organization through
functional interactions with telomeres and LAP2a.
Concluding remarks
We are just beginning to unravel the diversity and com-
plexity of functions of the NL and its associated binding
partners. Progress has been made in understanding dis-
ease processes andmore research is now focusing on the
basic cell biological mechanisms involved in NL homeo-
stasis, ranging from behavior of stem cells83 to regula-
tion of phospholipids84 and protein turnover in aging.85
The workshop in Baeza brought together leading scien-
tists from interrelated topics in the NL ﬁeld and fostered
stimulating discussions to pave the way for exciting
future discoveries that will be key to develop more efﬁ-
cient therapeutic strategies against laminopathies.
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